Skip to main content
. 2015 Jun 23;126(7):851–857. doi: 10.1182/blood-2015-01-621375

Table 4.

Initial treatment following transformed lymphoma

Treatment n (%)
Rituximab + chemotherapy 131 (34.6)
Rituximab monotherapy 98 (25.9)
Radiation 26 (6.9)
Chemotherapy 25 (6.6)
RIT 16 (4.2)
Investigational therapy 16 (4.2)
Stem cell transplantation 6 (1.8)
Combined modality: radiation 5 (1.3)
Other noninvestigational therapy 1 (0.3)
None 55 (14.5)

RIT, radioimmunotherapy.